July -
- Net sales for the third quarter amounted to
SEK 251.2 (231.5) million, an increase of 8.5 percent compared to the same quarter last year. Net sales in local currencies increased by 4.3 percent. -
Operating profit amounted to
SEK 31.7 (37.7) million, corresponding to an operating margin of 12.6 (16.3) percent. -
Profit after net financial items amounted to
SEK 30.9 (29.0) million. Net financial items were positively affected by exchange rate differences ofSEK 7.5 (-5.3) million and totaledSEK -0.8 (-8.7) million. -
Cash flow from operating activities was
SEK 29.0 (55.3) million, andSEK -25.1 (25.6) million after investments. -
Earnings per share amounted to
SEK 2.68 (2.71).
For further information, please contact:
Ewa Linsäter, Group CFO, +46 76 633 32 33, e-mail: ewa.linsater@elosmedtech.com
This disclosure contains information that
For additional information about the
https://news.cision.com/elos-medtech-ab/r/elos-medtech-interim-report-1-january---30-september--2023,c3856574
https://mb.cision.com/Main/1719/3856574/2369398.pdf
(c) 2023 Cision. All rights reserved., source